[Federal Register Volume 66, Number 102 (Friday, May 25, 2001)]
[Notices]
[Page 28913]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-13238]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting:

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:30 a.m.-6:45 p.m., June 20, 2001.
    8 a.m.-5:15 p.m., June 21, 2001.
    Place: Atlanta Marriott Century Center, 2000 Century
    Boulevard, N.E., Atlanta, Georgia 30345-3377.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters to be Discussed: The agenda will include a discussion on 
vaccine safety issues for yellow fever vaccine: Is a yellow fever 
vaccine booster needed every 10 years; adult high-risk hepatitis B 
immunization; current epidemiology of HBV infection in the US; 
status of immunization of high risk persons in STD clinics, prisons, 
and non-traditional settings; update on tetanus toxoid vaccine 
shortage; what should be CDC's role if the influenza vaccine supply 
remains unclear for the 2001-2002 season; summary of the live-
attenuated influenza vaccine working group meeting; vaccine safety 
updates: the Brighton collaboration, Institute of Medicine Report on 
measles, mumps and rubella vaccine and autism; update on thimerosal; 
update from the National Center for Infectious Diseases; update from 
the National Immunization Program; update from the Food and Drug 
Administration; update from the National Institutes of Health; 
update from the Vaccine Injury Compensation Program; update from the 
National Vaccine Program; final decision on general recommendations 
for immunization; discontinuation of human rabies vaccine for 
intradermal pre-exposure use; update on current phase III HIV 
vaccine efficacy trials; update on risk of meningococcal disease 
among microbiology laboratory workers; use of economic evaluation 
for setting health policy; recommended childhood immunization 
schedule, 2002; and should there be an immunization schedule for 
adult immunization.
    Agenda items are subject to change as priorities dictate.
    For Further Information Contact: Gloria A. Kovach, Program 
Analyst, Epidemiology and Surveillance Division, National 
Immunization Program, CDC, 1600 Clifton Road, NE, m/s E61, Atlanta, 
Georgia 30333. Telephone 404/639-8096.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.


    Dated: May 21, 2001.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 01-13238 Filed 5-24-01; 8:45 am]
BILLING CODE 4163-18-P